Jan Koenig

Title: Jan Koenig: Innovator in Pharmaceutical Chemistry

Introduction

Jan Koenig is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with antihypertensive properties. His work has implications for the treatment of hypertension, a condition affecting millions worldwide.

Latest Patents

Jan Koenig holds a patent for "Substituted acylpiperazinoquinazolines and pharmaceutical compositions." This patent describes substituted acylpiperazinoquinazolines of a specific formula, where n can be 0 or 1, and R represents an alkyl group with 1 to 4 carbon atoms or a benzyl group. The compounds exhibit significant antihypertensive activity and can be prepared through a reaction involving 2-halogeno quinazoline derivatives and acylpiperazines. The resulting acid addition salts, particularly hydrochlorides, are soluble in water and suitable for various medicinal dosage forms.

Career Highlights

Jan Koenig is associated with Spofa, Spojene Podniky Pro Zdravotnickou Vyrobu, a company dedicated to healthcare product manufacturing. His innovative work in pharmaceutical compositions has positioned him as a key figure in the industry.

Collaborations

Throughout his career, Jan has collaborated with notable colleagues, including Miroslav Rajsner and Vaclav Trcka. These partnerships have contributed to the advancement of research and development in pharmaceutical sciences.

Conclusion

Jan Koenig's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a significant inventor in the field. His work continues to impact the development of effective treatments for hypertension.